• About
  • Masthead
  • License Content
  • Advertise
  • Press Releases
  • Newsroom
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

Sign in
SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
    • Physician Pay by Specialty
    • ICD-10 Code Lookup
    • FDA Drug Approvals
    • Drug Safety for Breastfeeding/Pregnancy
    • Clinical Guidelines
    • Medical Calculators
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
  • Rankings
    • Medical School Rankings
    • Residency Rankings
  • Partners
    • License Content
    • Advertise with Us
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
    • Physician Pay by Specialty
    • ICD-10 Code Lookup
    • FDA Drug Approvals
    • Drug Safety for Breastfeeding/Pregnancy
    • Clinical Guidelines
    • Medical Calculators
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
  • Rankings
    • Medical School Rankings
    • Residency Rankings
  • Partners
    • License Content
    • Advertise with Us
Sign in
SUBSCRIBE
2 Minute Medicine
Sign in
Subscribe
2 Minute MedicineFree on Google PlayGet
✦EvidencePulse™by 2 Minute Medicine3 reportsYou askedtop stroke trials 2026Synthesizing medical evidence...Top 2026 stroke trial results:OCEANIC — ischemic stroke: 6.2% vs 8.4%OPTION* — mRS 0–1: 43.6% vs 34.2%ORIENTAL* — mRS 0–2: 58.6% vs 46.6%*Higher sICH in intervention armsParticipants randomizedNOCEANIC12,327OPTION570ORIENTAL564Ask about guidelines or landmark trials...↑Try EvidencePulse™Ask the evidence. Get the signal.Try it now →
Home All Specialties Chronic Disease

Low-dose combined hormonal contraceptives may be effective in managing symptoms of polycystic ovarian syndrome without increasing the prevalence of metabolic syndrome

bySiwen Liu, MScandSimon Pan, MD
January 13, 2026
in Chronic Disease, Endocrinology, Obstetrics, Pharma
Reading Time: 2 mins read
Letrozole (Femara) boosts fertility of women with Polycystic Ovarian Syndrome
Share on FacebookShare on TwitterShare on LinkedIn

1. Low-dose combined hormonal contraceptives managed symptoms of polycystic ovarian syndrome (PCOS) without increasing the prevalence of metabolic syndrome among participants with hyperandrogenic PCOS and overweight/obesity.

Evidence Rating Level: 2 (Good)

Combined oral contraceptive pills (COCPs) have been used as first-line treatment for polycystic ovarian syndrome (PCOS) for decades. However, COCP use may increase blood pressure,  triglyceride levels, and cardiovascular disease (CVD) risk, especially for those with obesity and hyperandrogenic PCOS. Metformin is commonly prescribed to treat PCOS due to the role of insulin resistance in hyperandrogenism development. However, metformin has been found to be less effective than COCPs in managing PCOS. Combining metformin with COCP may improve outcomes. Studies examining the combined effect of these medications on CVD risk, especially metabolic syndrome (MetS), among women with hyperandrogenic PCOS are lacking. This study thus compared the impact of COCPs, metformin, and the combination of both on MetS in hyperandrogenic PCOS individuals with overweight/obesity. This multicenter, double-blind, randomized trial (COMET-PCOS) recruited participants between the ages of 18 and 40 years and body mass index (BMI) 25 and 48 kg/m2 with hyperandrogenic PCOS in Pennsylvania, USA, from January 15, 2018, to June 28, 2023. Participants were randomized 1:1:1 to 24 weeks of low-dose COCPs (20 μg ethinyl estradiol/0.15 mg desogestrol), metforminXR (2,000 mg), or both (Combined). The primary outcome was the prevalence of MetS at the end of the study, defined as the last completed standard visit ≥16 weeks or an early termination visit after 12 weeks. Of the 240 participants randomized, 169 participants (70.4%) completed the trial (mean age: 29.5 years; mean BMI: 35.6 kg/m2), of which 59 were in the COCP group, 65 in the metformin group, and 63 were in the combined group. At baseline, the prevalence of MetS was 31% and comparable across groups. At the end of the study, the prevalence of MetS was 28.8% (17/59) in the COCP group, 26.2% (17/65) in the metformin group, and 28.6% (17/59) in the Combined group. Between-group differences were non-significant. At the end of the study, the COCP group showed a decrease in waist circumference (mean change (MC) −2.23 cm; 95% CI [−3.98, −0.49]), BMI (MC −0.49 kg/m2; 95% CI [−0.88, −0.10]), and android fat mass (MC −167 g; 95% CI [−264, −71]) compared to baseline. These parameters did not change in the metformin-only group. The majority of participants (>64%) in the metformin and combined groups reported diarrhea, while 24.1% in the COCP group reported uterine bleeding. Overall, this study found that low-dose COCPs managed PCOS symptoms without increasing the prevalence of MetS among participants with hyperandrogenic PCOS and overweight/obesity. These results support the use of low-dose COCPs alone as first-line therapy for PCOS treatment in this population. Future longitudinal studies are needed to confirm this study’s findings.

Click here to read this study in PLOS ONE

FDA approvedFor obesity: Foundayo (orforglipron), Apr 1, 2026→

Image: PD

©2025 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

RELATED REPORTS

ERX1000 plus semaglutide increased weight loss and metabolic measures in diet-induced obese mice

Investigational retatrutide reduced knee osteoarthritis pain and body weight versus placebo in adults with obesity

Tags: contraceptivegynecologymetforminobesitypcosPolycystic Ovary Syndrome
Previous Post

One dose of human papillomavirus vaccine noninferior to two for preventing persistent infection

Next Post

Higher dose extended-release buprenorphine may reduce opioid use in patients with heavy fentanyl use

RelatedReports

A collection of pharmaceutical items including a blister pack of tablets, a pen-like device, and several blank labels or strips, suggesting medication for obesity management.
2MM Trial Briefs

ERX1000 plus semaglutide increased weight loss and metabolic measures in diet-induced obese mice

November 17, 2026
Knee osteoarthritis collage: a calm older man with a gray beard, a knee joint inset with teal cartilage and a knee brace
Endocrinology

Investigational retatrutide reduced knee osteoarthritis pain and body weight versus placebo in adults with obesity

November 17, 2026
Obesity measurement collage: a bathroom scale with a blank dial, a loose cloth measuring tape, an apple and a pear
Chronic Disease

Obesity associated with higher early-onset cancer risk among young Korean adults

November 13, 2026
Obesity treatment collage: a bathroom scale with a blank dial, a coiled tape measure and a bowl of fresh vegetables
2MM Trial Briefs

Once-monthly bofanglutide maintained weight loss over 24 weeks in topline phase 3 results

November 5, 2026
Next Post
Opioid prescribing collage: a calm man beside an amber pill bottle spilling white tablets onto a pill-counting tray

Higher dose extended-release buprenorphine may reduce opioid use in patients with heavy fentanyl use

Pain relief collage: an engraved nerve cell with a fading teal signal, a willow sprig with catkins and over-ear headphones

Certain cannabis-based products may offer modest reductions in pain

HIV care collage: a smiling middle-aged man with an awareness ribbon pinned to his shirt beside a sprig of olive leaves

Weekly islatravir plus lenacapavir maintains HIV virologic suppression

✦ EvidencePulse™ by 2 Minute Medicine 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... Try EvidencePulse™ Get the signal. Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

3-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Removing Race and Ethnicity From Dialysis Mortality Risk Adjustment Changes Facility Performance Rankings
  • AI Model Shows Promise in Predicting PTSD Risk Following Trauma
  • 2 Minute Medicine Rewind November 16, 2026
License Content
Terms of Use | Disclaimer
Cookie Policy

Get the app

Read 2 Minute Medicine on iPhone, iPad and Android.

Download on the App StoreGet it on Google Play
QR code for www.2minutemedicine.com/app
On a computer? Scan this with your phone’s camera.
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

3-day free trial · cancel anytime

Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free

Start 3-day free trial

Then $49.90/year.

Membership benefits

  • ✓100+ new physician-written study summaries monthly, 12,000+ searchable
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
  • ✓FDA drug approvals + clinical calculators

Already a member? Sign in

  • Get the app
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
    • Physician Pay by Specialty
    • ICD-10 Code Lookup
    • FDA Drug Approvals
    • Drug Safety for Breastfeeding/Pregnancy
    • Clinical Guidelines
    • Medical Calculators
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
  • Rankings
    • Medical School Rankings
    • Residency Rankings
  • Partners
    • License Content
    • Advertise with Us
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.